Balversa
Brand Name: Balversa
Generic Name: Erdafitinib
Active
Registration Number
DR-XY48332
Dosage Form
Film-Coated Tablet
Issuance Date
September 1, 2022
Expiry Date
September 1, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength5 mg
PackagingPVC-PCTFE Foil Blister with an Aluminum Push through Foil in a Wallet Pack x 28's (Box of 28's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic Agent [Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor]
A
Application
Monitored Release
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
ErdafitinibActive
Monograph: Erdafitinib